Effect of interleukin 10 on the release of the CXC chemokines growth related oncogene GRO-α and epithelial cell-derived neutrophil activating peptide (ENA)-78 during human endotoxemia

This publication has 19 references indexed in Scilit:

• Chemotactic Activity of CXC Chemokines Interleukin‐8, Growth‐Related Oncogene–α, and Epithelial Cell–Derived Neutrophil‐Activating Protein–78 in Urine of Patients with Urosepsis
  The Journal of Infectious Diseases, 2000
• Interleukin 10 Inhibits the Release of CC Chemokines during Human Endotoxemia
  The Journal of Infectious Diseases, 2000
• Chemokines — Chemotactic Cytokines That Mediate Inflammation
  New England Journal of Medicine, 1998
• Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
  Journal of Clinical Investigation, 1995
• Interleukin-4 and Interleukin-10 Increase Endotoxin-Stimulated Human Umbilical Vein Endothelial Cell Interleukin-8 Release
  Journal of Interferon & Cytokine Research, 1995
• Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts
  European Journal of Immunology, 1995
• Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.
  The Journal of Experimental Medicine, 1993
• Interleukin 10 protects mice from lethal endotoxemia.
  The Journal of Experimental Medicine, 1993
• Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
  The Journal of Experimental Medicine, 1993
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991